{
    "eid": "2-s2.0-85131439861",
    "title": "Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "immunogenicity",
        "RA",
        "reactogenicity",
        "safety",
        "SARS-CoV-2 vaccine",
        "SLE"
    ],
    "authors": [
        "Theerada Assawasaksakul",
        "Tanat Lertussavavivat",
        "Seelwan Sathitratanacheewin",
        "Nont Oudomying",
        "Preeyaporn Vichaiwattana",
        "Nasamon Wanlapakorn",
        "Yong Poovorawan",
        "Yingyos Avihingsanon",
        "Nawaporn Assawasaksakul",
        "Supranee Buranapraditkun",
        "Wonngarm Kittanamongkolchai"
    ],
    "citedby-count": 7,
    "ref-count": 28,
    "ref-list": [
        "SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates",
        "Efficacy of covid-19 vaccines in immunocompromised patients: Systematic review and meta-analysis",
        "Comparing the clinical efficacy of COVID-19 vaccines: A systematic review and network meta-analysis",
        "Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2: A Prospective Cohort Study",
        "Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases",
        "Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis",
        "Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus",
        "BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients",
        "Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac\u2014PROFISCOV: A structured summary of a study protocol for a randomised controlled trial",
        "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: A randomised, double-blind, placebocontrolled, phase 1/2 clinical trial",
        "Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies",
        "Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study",
        "Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan",
        "Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination",
        "Immunological mechanisms of vaccine-induced protection against COVID-19 in humans",
        "SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees",
        "CD8+T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes from Multiple Prominent SARS-CoV-2 Circulating Variants",
        "Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: A cross-sectional study",
        "Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: A post-vaccination cross-sectional survey",
        "Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination",
        "Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination",
        "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60011384",
            "affilname": "BNH Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011384",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Health Systems Research Institute"
    ]
}